- 542665 - Clarification sought from Neogen Chemicals Ltd
The Exchange has sought clarification from Neogen Chemicals Ltd on 13th February, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached Investors Presentation for the quarter and nine months ended December 31, 2019 - 542665 - Outcome Of Board Meeting Held On Saturday, February 8, 2020.
With regards to the captioned matter and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we enclose herewith Un-audited Financial Results (Standalone and Consolidated basis) for the quarter and nine months ended December 31, 2019, along with Limited Review Report duly submitted by the Statutory Auditors of the company which has been duly reviewed and recommended by the Audit Committee. The above unaudited financial results were approved by the Board of Directors of the Company at its meeting held today which commenced at 12:00 Noon and concluded at 6.00 P.M. Neogen Chemicals Ltd - 542665 - Sub: Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015. Ref.: SEBI Circular No. CIR/CFD/CMD1/162/2019 Dated December 24, 2019
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations), we enclose herewith Statement of Deviation / Variation in utilization of funds raised ('Statement') as at December 31, 2019, which has been duly reviewed and recommended by the Audit Committee. Further there was no unutilized amount as at December 31, 2019 and no Deviation/ Variation occurred in the object/ utilization of IPO proceeds. Kindly take the above on your record and disseminate the same for the information of investors. Neogen Chemicals Ltd - 542665 - Outcome Of Board Meeting Held On Saturday, February 8, 2020.
With regards to the captioned matter and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (Listing Regulations), we enclose herewith Un-audited Financial Results (Standalone and Consolidated basis) for the quarter and nine months ended December 31, 2019, along with Limited Review Report duly submitted by the Statutory Auditors of the company which has been duly reviewed and recommended by the Audit Committee. The above unaudited financial results were approved by the Board of Directors of the Company at its meeting held today which commenced at 12:00 Noon and concluded at 6.00 P.M. Kindly take the above on your record and disseminate the same for the information of investors. Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will participate in the earning conference call on Monday, February 10, 2020 at 1:00 p.m. IST for analysts and investors to discuss the Q3 & 9M F.Y. 2019-20 financial results. Note: 1. No Unpublished Price Sensitive Information will be shared during the call. - 542665 - Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2019.
Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2020 ,inter alia, to consider and approve Pursuant to regulation 29, 33 read with regulation 47 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, notice is hereby given that the meeting of the Board of Directors of the Company is schedule to be held on Saturday, February 08, 2020, inter-alia, to consider and approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on December 31, 2019. Further, as we have informed vide our letter dated December 31, 2019, the trading window closure period had commenced from January 1, 2020 and will end 48 hours after the declaration of Unaudited financial results of the Company for the quarter and nine months ended December 31, 2019 pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 are made public. This information is also being uploaded on the Company's Website at www.neogenchem.com - 542665 - Shareholding for the Period Ended December 31, 2019
Neogen Chemicals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here Neogen Chemicals Ltd - 542665 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of analysts and investors have been organized on Monday, January 13, 2020 at Company's Registered Office. The discussion in the meeting will be under the purview of Neogen Chemicals' Q2 and H1 (FY19-20) Earnings Presentation which has already been uploaded on the websites of BSE Limited and National Stock Exchange of India Limited and also on the Company website www.neogenchem.com Note: 1. Date of the aforesaid meetings are subject to change due to exigencies on the part of Investors / Company. 2. No Unpublished Price Sensitive Information will be shared during the meetings. - 542665 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Unnati KananiDesignation :- Company Secretary and Compliance Officer